Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Mendelson

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
Plos Medicine|October 30, 2013
Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control studyMyrsini Kaforou, Victoria J Wright, Tolu Oni, et al.
Annals of Internal Medicine|May 12, 2015
Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the GeoSentinel Surveillance NetworkAndrea K Boggild, Douglas H Esposito, Phyllis E Kozarsky, et al.
The Lancet Regional Health. Europe|September 24, 2021
Optimising antimicrobial use in humans - review of current evidence and an interdisciplinary consensus on key priorities for researchEsmita Charani, Martin McKee, Raheelah Ahmad, et al.
Antimicrobial Resistance and Infection Control|November 27, 2020
A one health framework to estimate the cost of antimicrobial resistanceChantal M Morel, Richard A Alm, Christine Årdal, et al.
American Journal of Public Health|March 23, 2022
Governing Global Antimicrobial Resistance: 6 Key Lessons From the Paris Climate AgreementIsaac Weldon, Susan Rogers Van Katwyk, Gian Luca Burci, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 11, 2024
WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infectionsLorenzo Moja, Veronica Zanichelli, Dominik Mertz, et al.
BMC Infectious Diseases|June 20, 2022
Clinical features and outcomes of COVID-19 admissions in a population with a high prevalence of HIV and tuberculosis: a multicentre cohort studyArifa Parker, Linda Boloko, Muhammad S Moolla, et al.
JAMA|September 13, 2018
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical TrialPatrick N A Harris, Paul A Tambyah, David C Lye, et al.
Tropical Medicine & International Health : TM & IH|April 12, 2022
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South AfricaMary-Ann Davies, Reshma Kassanjee, Petro Rousseau, et al.
The Lancet. Infectious Diseases|March 18, 2020
Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient dataDavid A Barr, Joseph M Lewis, Nicholas Feasey, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Plos Medicine|October 30, 2013
Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control studyMyrsini Kaforou, Victoria J Wright, Tolu Oni, et al.
Annals of Internal Medicine|May 12, 2015
Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the GeoSentinel Surveillance NetworkAndrea K Boggild, Douglas H Esposito, Phyllis E Kozarsky, et al.
The Lancet Regional Health. Europe|September 24, 2021
Optimising antimicrobial use in humans - review of current evidence and an interdisciplinary consensus on key priorities for researchEsmita Charani, Martin McKee, Raheelah Ahmad, et al.
Antimicrobial Resistance and Infection Control|November 27, 2020
A one health framework to estimate the cost of antimicrobial resistanceChantal M Morel, Richard A Alm, Christine Årdal, et al.
American Journal of Public Health|March 23, 2022
Governing Global Antimicrobial Resistance: 6 Key Lessons From the Paris Climate AgreementIsaac Weldon, Susan Rogers Van Katwyk, Gian Luca Burci, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 11, 2024
WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infectionsLorenzo Moja, Veronica Zanichelli, Dominik Mertz, et al.
BMC Infectious Diseases|June 20, 2022
Clinical features and outcomes of COVID-19 admissions in a population with a high prevalence of HIV and tuberculosis: a multicentre cohort studyArifa Parker, Linda Boloko, Muhammad S Moolla, et al.
JAMA|September 13, 2018
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical TrialPatrick N A Harris, Paul A Tambyah, David C Lye, et al.
Tropical Medicine & International Health : TM & IH|April 12, 2022
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South AfricaMary-Ann Davies, Reshma Kassanjee, Petro Rousseau, et al.
The Lancet. Infectious Diseases|March 18, 2020
Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient dataDavid A Barr, Joseph M Lewis, Nicholas Feasey, et al.
Pageof 17